(Q38243754)

31 August 2017

title

Toll like receptors: a new hope on the horizon to treat multiple sclerosis (English)

1 reference

31 August 2017

0 references

4

1 reference

Amir Hossein Abdolghaffari

31 August 2017

object named as

Amir Hossein Abdolghaffari

series ordinal

3

0 references

author name string

Maziar Gooshe

series ordinal

1

1 reference

31 August 2017

Ali Reza Aleyasin

series ordinal

2

1 reference

31 August 2017

publication date

27 August 2014

1 reference

Expert Review of Clinical Immunology

31 August 2017

published in

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

10

1 reference

31 August 2017

page(s)

1277-1279

1 reference

Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis.

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Multiple sclerosis: an immune or neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Current and emerging therapies in multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Immunology of relapse and remission in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Therapeutic targeting of pattern-recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Pathogen recognition by innate immunity and its signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Prophylactic and therapeutic implications of toll-like receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Toll-like receptors as potential therapeutic targets for multiple diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

Negative regulation of Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.953061

10.1586/1744666X.2014.953061

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference